Xing Zhang

Dr. Xing Zhang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Journal of Integrative Medicine
Verified
Journal Article
Closed access
MSMiao-Yan Shi
Miao-Yan Shi
SSShi-Qi Sun
Shi-Qi Sun
WZWei Zhang
Wei Zhang
XZXing Zhang
Xing Zhang
GXGui-Hua Xu
Gui-Hua Xu
YLYun-Fei Lu
Yun-Fei Lu

17 May 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
XZXing Zhang
Xing Zhang
JSJie Su
Jie Su
JLJiacheng Lin
Jiacheng Lin
LLLujiong Liu
Lujiong Liu
JWJiamin Wu
Jiamin Wu
WZWei Zhang
Wei Zhang

12 October 2024 in Gene
Verified
Journal Article
Closed access
XZXing Zhang
Xing Zhang
JLJiacheng Lin
Jiacheng Lin
DZDongliang Zuo
Dongliang Zuo
XCXuan Chen
Xuan Chen
GXGuihua Xu
Guihua Xu
WZWei Zhang
Wei Zhang

26 June 2023 in Proceedings of the AAAI Conference on Artificial Intelligence
Verified
Journal Article
Open access
PDF file
KXKun Xiang
Kun Xiang
XZXing Zhang
Xing Zhang
JSJinwen She
Jinwen She
JLJinpeng Liu
Jinpeng Liu
HWHaohan Wang
Haohan Wang
SJShancheng Jiang
Shancheng Jiang
As the COVID-19 pandemic puts pressure on healthcare systems worldwide, the computed tomography image based AI diagnostic system has become a sustainable solution for early diagnosis. However, the model-wise vulnerability under adversarial perturbation hinders its deployment in practical situation. The existing adversarial training strategies are difficult to generalized into medical imaging field challenged by complex medical texture features. To overcome this challenge, we propose a Contour Attention Preserving (CAP) method based on lung cavity edge extraction. The contour prior features are injected to attention layer via a parameter regularization and we optimize the robust empirical risk with hybrid distance metric. We then introduce a new cross-nation CT scan dataset to evaluate the generalization capability of the adversarial robustness under distribution shift. Experimental results indicate that the proposed method achieves state-of-the-art performance in multiple adversarial defense and generalization tasks. The code and dataset are available at https://github.com/Quinn777/CAP.

28 September 2026 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
QSQing Shen
Qing Shen
FZFengjun Zhang
Fengjun Zhang
FWFan Wu
Fan Wu
YWYilin Wang
Yilin Wang
ZSZijian Su
Zijian Su
WZWei Zhang
Wei Zhang
Community-acquired pneumonia (CAP) still causes high mortality despite effective antibiotics. Much of this death is driven by a dysregulated host immune response rather than by the pathogen itself, and antimicrobial resistance deepens the problem. Host-directed therapy has accordingly shifted toward precision immunomodulation, yet its benefit appears conditional on the inflammatory state. Stratification by a single inflammator y axis such as C-reactive protein (CRP) separates broad prognostic subgroups, but it does not indicate which effector pathway to target or which agent to use; we designate this limitation, as a conceptual shorthand rather than a validated threshold, the “CRP ceiling.” Existing reviews treat natural-product host-directed therapy, CAP inflammatory endotyping, and human lung organoid modeling separately; the gap we address is the absence of a framework that connects them. Integrating these three fields, we propose, as a hypothesis-generating rather than a validated scheme, an endotype–target–natural-product framework for bacterial CAP. We first outline the interventable core of CAP immunopathology across the inflammasome, neutrophil extracellular trap (NET), and resolution axes, together with the pathogen-specific virulence that biases them; we then propose that the multi-target pharmacology of natural products may suit candidate endotypes driven by several co-activated nodes, where single-target agents have often failed, while noting that their comparatively favorable toxicity is itself a hypothesis rather than an established class property; and we position human lung organoids as a promising human-relevant platform, alongside complementary systems, that could test endotype-, compound-, and pathogen-specific hypotheses and provide a roadmap for validation before clinical translation. The framework is intended to complement, not replace, pathogen-directed treatment, and to reframe host-directed therapy from uniform anti-inflammation toward modulation matched to mechanism, pathogen, and patient. The principal challenges concern immune-competent organoids, validated pathway-level endotype biomarkers, and standardized characterization of multi-component natural products.

30 November 2022 in arXiv
Verified
Preprint
Open access
PDF file
KXKun Xiang
Kun Xiang
XZXing Zhang
Xing Zhang
JSJinwen She
Jinwen She
JLJinpeng Liu
Jinpeng Liu
HWHaohan Wang
Haohan Wang
SJShancheng Jiang
Shancheng Jiang
As the COVID-19 pandemic puts pressure on healthcare systems worldwide, the computed tomography image based AI diagnostic system has become a sustainable solution for early diagnosis. However, the model-wise vulnerability under adversarial perturbation hinders its deployment in practical situation. The existing adversarial training strategies are difficult to generalized into medical imaging field challenged by complex medical texture features. To overcome this challenge, we propose a Contour Attention Preserving (CAP) method based on lung cavity edge extraction. The contour prior features are injected to attention layer via a parameter regularization and we optimize the robust empirical risk with hybrid distance metric. We then introduce a new cross-nation CT scan dataset to evaluate the generalization capability of the adversarial robustness under distribution shift. Experimental results indicate that the proposed method achieves state-of-the-art performance in multiple adversarial defense and generalization tasks. The code and dataset are available at https://github.com/Quinn777/CAP.